COM:AUTOLUS
Autolus Therapeutics plc
- Stock
Last Close
2.84
22/11 21:00
Market Cap
1.05B
Beta: -
Volume Today
1.60M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '16 | Sep '17 | Sep '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -12.55M - | -19.73M 57.19% | -31.11M 57.73% | -123.85M 298.04% | -142.09M 14.73% | -142.10M 0.00% | -148.84M 4.75% | ||
depreciation and amortization | 478K - | 1.01M 111.09% | 1.10M 9.51% | 4.61M 317.29% | 5.66M 22.71% | 8.46M 49.49% | 7.42M 12.25% | ||
deferred income tax | -5.21M - | -399K 92.34% | -1.34M 236.84% | -72K 94.64% | -268K 272.22% | ||||
stock based compensation | 2.26M - | 3.15M 39.70% | 5.03M 59.43% | 30.21M 501.02% | 20.11M 33.45% | 9.94M 50.58% | 12.01M 20.90% | ||
change in working capital | -1.23M - | -795K 35.52% | 5.42M 781.93% | -16.20M 398.89% | 1.41M 108.70% | 4.14M 193.48% | 3.97M 4.11% | ||
accounts receivables | |||||||||
inventory | |||||||||
accounts payables | 507K - | 434K 14.40% | 8.65M 1,893.71% | -1.45M 116.77% | 1.44M 199.17% | -1.82M 226.20% | 22K 101.21% | ||
other working capital | -1.74M - | -1.23M 29.37% | -3.23M 162.93% | -14.75M 356.55% | -29K 99.80% | 5.95M 20,631.03% | 3.95M 33.73% | ||
other non cash items | 1.20M - | -1.07M - | 4.14M 486.02% | -1.50M 136.07% | 1.77M 218.66% | 13.39M 655.07% | |||
net cash provided by operating activities | -9.85M - | -16.36M 66.11% | -25.85M 57.99% | -101.48M 292.63% | -117.76M 16.04% | -117.86M 0.09% | -112.31M 4.71% | -145.59M 29.63% | |
investments in property plant and equipment | -1.85M - | -2.88M 55.04% | -8.77M 204.98% | -18.67M 112.83% | -14.68M 21.36% | -8.86M 39.67% | -10.84M 22.40% | ||
acquisitions net | |||||||||
purchases of investments | |||||||||
sales maturities of investments | |||||||||
other investing activites | 1.13M - | -10.99M - | |||||||
net cash used for investing activites | -1.85M - | -2.88M 55.04% | -7.65M 165.83% | -18.67M 144.17% | -14.68M 21.36% | -8.86M 39.67% | -10.84M 22.40% | -10.99M 1.34% | |
debt repayment | |||||||||
common stock issued | 128.70M - | 108.86M 15.42% | 74.42M 31.64% | 245.90M 230.44% | 163.85M 33.37% | ||||
common stock repurchased | |||||||||
dividends paid | |||||||||
other financing activites | 32.22M - | 127.69M 296.27% | -11.22M 108.79% | 108.86M 1,070.40% | -5.80M 105.33% | 38.16M 758.32% | 59.76M 56.58% | -883K 101.48% | |
net cash used provided by financing activities | 32.22M - | 127.69M 296.27% | 117.49M 7.99% | 108.86M 7.34% | 74.42M 31.64% | 284.06M 281.73% | 223.61M 21.28% | -883K 100.39% | |
effect of forex changes on cash | -2.66M - | 561K 121.07% | 2.99M 432.15% | 5.16M 72.98% | 679K 86.85% | -754K 211.05% | -28.38M 3,663.40% | 15.03M 152.97% | |
net change in cash | 17.86M - | 109.01M 510.50% | 86.98M 20.21% | -6.13M 107.04% | -57.34M 836.24% | 156.59M 373.07% | 72.08M 53.97% | -142.43M 297.58% | |
cash at beginning of period | 10.20M - | 28.06M 175.01% | 102.32M 264.66% | 217.56M 112.62% | 211.43M 2.82% | 154.09M 27.12% | 310.68M 101.63% | ||
cash at end of period | 28.06M - | 137.07M 388.51% | 189.30M 38.10% | 211.43M 11.69% | 154.09M 27.12% | 310.68M 101.63% | 382.76M 23.20% | -142.43M 137.21% | |
operating cash flow | -9.85M - | -16.36M 66.11% | -25.85M 57.99% | -101.48M 292.63% | -117.76M 16.04% | -117.86M 0.09% | -112.31M 4.71% | -145.59M 29.63% | |
capital expenditure | -1.85M - | -2.88M 55.04% | -8.77M 204.98% | -18.67M 112.83% | -14.68M 21.36% | -8.86M 39.67% | -10.84M 22.40% | ||
free cash flow | -11.70M - | -19.24M 64.35% | -34.62M 79.97% | -120.15M 247.07% | -132.44M 10.23% | -126.72M 4.32% | -123.15M 2.82% | -145.59M 18.22% |
All numbers in USD (except ratios and percentages)